Angiotech's Licensee, Cook Medical, Enrolls First Renal Artery Disease Patient In Clinical Trial Of New Drug-eluting Stent
Links shared publicly online about this topic.
- 1,222total visits
Angiotech's Licensee, Cook Medical, Enrolls First Renal Artery Disease Patient In Clinical Trial Of New Drug-eluting Stent
Angiotech Pharmaceuticals, Inc. ( ANPI, TSX: ANP) announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula(TM) PTX(R)
View full resource at medicalnewstoday.com
Tags: Circulation, Kidney Health, Urinary System, Disease and Condition, Cooking, Clinical Trial, disease, Medical
Most Recently Shared on April 22, 2010 at 4:16 pm By:
Angiotech's Licensee, Cook Medical, Enrolls First Renal Artery Disease Patient In Clinical Trial Of New Drug-eluting S... http://mnt.to/3BBm
Also Shared By:
Advertisement
MNT Vascular
@mnt_vascular
Angiotech's Licensee, Cook Medical, Enrolls First Renal Artery Disease Patient In Clinical Trial Of New Drug-eluting S... http://mnt.to/3BBm
1 year ago...